Preclinical study shows promise of systemic targeted therapy in a rare form of cancer
Estimated read time 1 min read
Posted in Health Trends Health Trends - UK

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

admin

Treatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600E PMP-PDX tumors without impacting in apoptosis. a–d) Mice bearing subcutaneous BRAF mutant PMP-PDX tumors (PMP5.1) were treated with…

[ad_2]

Source link

You May Also Like

More From Author

Bat dropped off at Toronto animal hospital tested positive for rabies

Bat dropped off at Toronto animal hospital tested positive for rabies

Pharmacists and community health workers lead successful hypertension interventions

Pharmacists and community health workers lead successful hypertension interventions

Leave a Reply

Your email address will not be published. Required fields are marked *